Titan Pharmaceuticals Inc.
TTNP
NSC
Sector: Healthcare
Industry: Biotechnology
1.45
USD
0.11
(8.21%)
Optionable: Yes Market Cap: 19 M 90-day average vol: 793,052
Previous close: 1.34 Open: 1.34 Bid: 1.45 Ask: 1.45
52 week range
0.35 2.38
Last updated: Friday 5th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 31.93 |
Price per Book TTM ($) | 2.34 |
PE Ratio (TTM) | -1.50 |
Book Value per Share ($) | 0.54 |
5 Year PE Range-1.8 |
Returns
7 Day Return | 14.17% | |
1 Month Return | 139.67% | |
3 Month Return | 116.77% | |
1 Year Return | -35.27% | |
3 Year Return | -95.44% | |
5 Year Return | -99.56% | |
YTD Return | 42.16% |
Risk
Custom Beta One Year | 1.16 |
Custom Beta Three Years | 0.73 |
Beneish M Score | 0.00 |
Altman Z Score | -65.93 |
Financial Health
Technicals
RSI (14 Day) | 67.18 |
14 Day SMA ($) | 1.32 |
14 Day EMA ($) | 1.28 |
Money Flow Index | 26.28 |
Average True Range | 0.13 |
50 Day SMA ($) | 0.85 |
200 Day SMA ($) | 1.04 |
ADX | 46.26 |
MACD | 0.14 |
Growth
Free Cash Flow QoQ Growth | 172.93% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -7.69% |
Revenue QoQ Growth | 42.22% |
EPS YoY Growth | 0.00% |
Profitability
Return on Assets TTM (%) | -74.23 |
Profit Margin TTM (%) | -893.2 |
Return on Equity TTM (%) | -100.25 |
Return on Capital TTM (%) | -91.94 |
Interest Coverage Ratio | -9,048.90 |
Gross Margin TTM (%) | 36.0 |
Chart
News
Titan Pharmaceuticals Raises $5.5M Via Equity
Yahoo Finance 2/2/2022
Titan Pharmaceuticals to raise $5.5M in stock and pre-funded warrant offering
Seeking Alpha 2/2/2022
Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market
Yahoo Finance 2/2/2022
Titan Pharma to evaluate strategic alternatives
Seeking Alpha 12/21/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 46.532
Financials
TTNP Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 M | 10 M | 4 M | 2 M | 15 M | 215000 | 7 M | 3 M | 5 M | 2 M |
| Cost of sales | -17000 | -107000 | -353000 | -358000 | -377000 | -417000 | 158000 | -244000 | 180000 | -22000 |
| Gross operating profit | 7 M | 10 M | 4 M | 2 M | 15 M | 215000 | 5 M | 315000 | 67000 | 50000 |
| Selling Gen & administrative expense | 5 M | 3 M | 3 M | 4 M | 5 M | 5 M | 7 M | 5 M | 6 M | 5 M |
| Research & development expense | 11 M | 8 M | 4 M | 5 M | 6 M | 10 M | 7 M | 5 M | 6 M | 6 M |
| Operating income | -8 M | -891000 | -3 M | -7 M | 4 M | -15 M | -8 M | -8 M | -7 M | -9 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -2 M | 12 M | 1 M | -5 M | 755000 | 564000 | 128000 | 1 M | 713000 | 577000 |
| Pre-tax Income (EBT) | -15 M | 10 M | -2 M | -11 M | 5 M | -14 M | -9 M | -7 M | -7 M | -9 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -15 M | 10 M | -2 M | -11 M | 5 M | -14 M | -9 M | -16 M | -18 M | -9 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -15 M | 10 M | -2 M | -11 M | 5 M | -14 M | -9 M | -16 M | -18 M | -9 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -15 M | 10 M | -2 M | -11 M | 5 M | -14 M | -9 M | -7 M | -7 M | -9 M |
| Depreciation | 17000 | 107000 | 353000 | 358000 | 377000 | 417000 | 380000 | 244000 | 292000 | 221000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -8 M | -784000 | -3 M | -6 M | 5 M | -14 M | -8 M | -6 M | -7 M | -9 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -227.7 | 118.8 | -29.7 | -100.8 | 45 | -121.53 | -49.2 | -21.6 | -4.83 | -0.9 |
| Diluted EPS total | -227.7 | 99 | -39.6 | -100.8 | 36 | -126.63 | -49.8 | -21.6 | -4.83 | -0.9 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!